Cytokine-secreting tumor cell vaccines

This publication has 46 references indexed in Scilit:

• Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response
  The Journal of Experimental Medicine, 1999
• Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine
  Gene Therapy, 1999
• Interleukin-2 Gene-Modified Allogeneic Tumor Cells for Treatment of Relapsed Neuroblastoma
  Human Gene Therapy, 1998
• Enhanced Tumor Protection by Granulocyte-Macrophage Colony-Stimulating Factor Expression at the Site of an Allogeneic Vaccine
  Human Gene Therapy, 1998
• Requirement for V _α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
  Science, 1997
• Limited Antitumor T Cell Response in Melanoma Patients Vaccinated with Interleukin-2 Gene-Transduced Allogeneic Melanoma Cells
  Human Gene Therapy, 1996
• Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
  Science, 1994
• Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
  JNCI Journal of the National Cancer Institute, 1989
• TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
  Annual Review of Immunology, 1989
• In vitro actions on hemopoietic cells of recombinant murine GM‐CSF purified after production in Escherichia coli: Comparison with purified native GM‐CSF
  Journal of Cellular Physiology, 1986